Sijun Liu

Dr. Sijun Liu

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Nanotoxicology
Verified
Journal Article
Closed access
WZWanling Zhao
Wanling Zhao
JDJinqiong Deng
Jinqiong Deng
YRYan Ren
Yan Ren
LXLiyuan Xie
Liyuan Xie
WLWeirong Li
Weirong Li
SLSijun Liu
Sijun Liu
Metal–organic frameworks (MOFs), which are also referred to as coordination polymers, have been widely used in adsorption separation and catalysis, especially in the field of physical chemistry in the past few years, because of their unique physical structure and potential chemical properties. In recent years, particularly with the continuous expansion of the research field, deepening of research levels, and sustained advancements in science and technology, powerful and diverse MOFs that have demonstrated great biomedical application potential have been successively developed. Consequently, this study summarizes the origin, development, and common synthesis methods of MOFs, with major emphasis on their antibacterial application and safety evaluation in biomedicine.

14 April 2023 in Molecules
Verified
Journal Article
Open access
PDF file
XCxingru Chen
xingru Chen
XZXiaolan Zhou
Xiaolan Zhou
XCXiaoqing Cheng
Xiaoqing Cheng
LLLiting Lin
Liting Lin
QWQi Wang
Qi Wang
SLSijun Liu
Sijun Liu
In neurodegenerative diseases, microglial activation and neuroinflammation are essential for the control and progression of neurodegenerative diseases. Mitigating microglium-induced inflammation is one strategy for hindering the progression of neurodegenerative diseases. Ferulic acid (FA) is an effective anti-inflammatory agent, but its potential role and regulation mechanism in neuroinflammatory reactions have not been fully studied. In this study, the neuroinflammation model was established by lipopolysaccharide (LPS), and the inhibitory effect of FA on neuroinflammation of BV2 microglia was studied. The results showed that FA significantly reduced the production and expression of reactive oxygen species (ROS), tumor necrosis factor-α (TNF-α), leukocyte-6 (IL-6) and interleukin-1β (IL-1β). We further studied the mechanism of FA’s regulation of LPS-induced BV2 neuroinflammation and found that FA can significantly reduce the expression of mTOR in BV2 microglia induced by LPS, and significantly increase the expression of AMPK, indicating that FA may have an anti-inflammatory effect by activating the AMPK/mTOR signaling pathway to regulate the release of inflammatory mediators (such as NLRP3, caspase-1 p20 and IL-1β). We further added an autophagy inhibitor (3-MA) and an AMPK inhibitor (compound C, CC) for reverse verification. The results showed that FA’s inhibitory effects on TNF-α, IL-6 and IL-1β and its regulatory effect on AMPK/mTOR were destroyed by 3-MA and CC, which further indicated that FA’s inhibitory effect on neuroinflammation is related to its activation of the AMPK/mTOR autophagy signaling pathway. In a word, our experimental results show that FA can inhibit LPS-induced neuroinflammation of BV2 microglia by activating the AMPK/mTOR signaling pathway, and FA may be a potential drug for treating neuroinflammatory diseases.

18 April 2023 in Journal of Pharmacological Sciences
Verified
Journal Article
Open access
XZXiaolan Zhou
Xiaolan Zhou
XCXingru Chen
Xingru Chen
XCXiaoqing Cheng
Xiaoqing Cheng
LLLiting Lin
Liting Lin
SQShijian Quan
Shijian Quan
SLSijun Liu
Sijun Liu
Microglia hyperactivation is an important cause of neuroinflammation in Alzheimer's disease (AD). Paeoniflorin (PF), ferulic acid (FA), and atractylenolide III (ATL) are potent in anti-inflammation and neuroprotection. Multiple components can act on different targets simultaneously to exert synergistic therapeutic effects and exploring the synergistic potential between compounds is an important area of research. We investigated the effects of PF, FA, and ATL, alone or in combination, on LPS-induced neuroinflammation and autophagy in BV2 microglia cells. We found that PF, FA, and ATL, alone or in combination, significantly reduced the production of inflammatory factors such as IL-6, IL-1β, and TNF-α, especially in the PF + FA + ATL group, which performed the best. In addition, the combination of PF, FA, and ATL significantly increased the expression of autophagy-related proteins p-AMPK, p-ULK1, Beclin1, LC3, and TFEB and decreased the expression of p62. Moreover, the restoration of autophagic flux by the combination of PF, FA, and ATL was abrogated by the addition of the autophagy inhibitor Wortmannin. In conclusion, PF, FA, and ATL have a synergistic effect in reducing LPS-induced inflammatory factor release from BV2 microglia cells, and its protective effect may be through activation of the AMPK/ULK1/TFEB autophagic signaling pathway.

1 January 2020 in American Journal of Alzheimer's Disease and Other Dementias®
Verified
Journal Article
Open access
PDF file
CZChengCheng Zhou
ChengCheng Zhou
QWQingguang Wu
Qingguang Wu
ZWZongwei Wang
Zongwei Wang
QWQi Wang
Qi Wang
YLYouya Liang
Youya Liang
SLSijun Liu
Sijun Liu
Previous studies have indicated that estrogen may delay disease progression and minimize the cognitive decline in patients with Alzheimer's disease (AD). However, the evidence for an estrogen deficiency in women with dementia and cognitive dysfunction is inconsistent. In the present review, a fixed effect meta-analysis revealed that the hormone replacement therapy (HRT) group exhibited significant improvements in Alzheimer Disease Assessment Scale-Cognitive subscale scores relative to those observed in the placebo group, suggesting that HRT is feasible for treating cognitive decline in patients with AD. However, no significant differences in Mini-Mental State Examination and Clinical Dementia Rating scale scores were observed between the 2 groups. The results of our systematic review indicate that HRT can improve cognitive function in female patients with AD. Due to limitations in sample size and the available literature, further multicenter trials with larger sample sizes are required to support these findings.

30 October 2017 in International Journal of Biometeorology
Verified
Journal Article
Closed access
PDF file
SLSijun Liu
Sijun Liu
JCJiaping Chen
Jiaping Chen
JWJianming Wang
Jianming Wang
ZWZhuchao Wu
Zhuchao Wu
WWWeihua Wu
Weihua Wu
HSHongbing Shen
Hongbing Shen

1 December 2015 in Complementary Therapies in Medicine
Verified
Journal Article
Closed access
JGJing Gao
Jing Gao
QWQi Wang
Qi Wang
SXShaoxiang Xian
Shaoxiang Xian
YFYue-Mei Feng
Yue-Mei Feng
WCWei-Xin Cao
Wei-Xin Cao
SLSijun Liu
Sijun Liu